Teste de viabilidade in vitro de pólen de pessegueiro usando diferentes fontes de açúcar.

O objetivo deste trabalho foi testar outros carboidratos em substituição a sacarose, a fim de encontrar alternativas igualmente eficientes e com menor custo

Associação de marcadores moleculares do BTA14 com espessura de gordura em bovinos da raça Canchim.

bitstream/CPPSE/16677/1/PROCIMMA2006.00247.PD

Characterization of South American Snails of the Genus Biomphalaria

The identification of snails of the genus Biomphalaria can be done using morphological characteristics which depends on the size of the snails and skill and knowledge of researcher. These methods sometimes are not adequate for identification of species. The PCR-RFLP, using the ITS region of the rDNA, has been used to identify Brazilian species of the genus Biomphalaria. Nevertheless, there is a lack of information about snails from other Latin American countries. In addition, some snails may be infected by Schistosoma mansoni and when submitted to PCR-RFLP they show molecular profiles different from those previously standardized for the other mollusc species. In this work the molecular profiles of 15 species and the subspecies were established by PCR-RFLP of ITS-rDNA with the enzyme DdeI. Moreover, the molecular profiles of host species, B. glabrata, B. straminea, B. tenagophila, and B. prona, infected by S. mansoni were also established. The molluscs were dissected to permit morphological identification. These results contribute to a correct identification of snails of the genus Biomphalaria and detection of these snails infected by S. mansoni

Efficacy of the Pentavalent Rotavirus Vaccine, RotaTeq (RV5), Between Doses of a 3-Dose Series and With Less Than 3 Doses (Incomplete Regimen)

Post-hoc analyses of the Rotavirus Efficacy and Safety Trial (RES T) were conducted to determine whether the pentavalent rotavirus vaccine (RV5) confers early protection against rotavirus gastroenteritis (RVGE) before completion of the 3-dose regimen. To evaluate the efficacy of RV5 between doses in reducing the rates of RVGE-related hospitalizations and emergency department (ED) visits in infants who ultimately received all 3 doses of RV5/placebo, events occurring from 2 weeks after the first and second doses to receipt of the subsequent dose (Analysis A) and events occurring from 2 weeks after the first and second doses to 2 weeks after the subsequent dose (Analysis B) were analyzed. In Analysis A, RV5 reduced the rates of combined hospitalizations and ED visits for G1-G4 RVGE or RVGE regardless of serotype between doses 1 and 2 by 100% [95% confidence interval (CI): 72-100%] or 82% (95% CI: 39-97%), respectively, and between doses 2 and 3, RV5 reduced the rates of combined hospitalizations and ED visits for G1-G4 RVGE or RVGE regardless of serotype by 91% (95% CI: 63-99%) or 84% (95% CI: 54-96%), respectively. Similar rate reductions were observed in Analysis B. These data suggest that RV5 provides a high level of protection between doses against hospitalizations and ED visits for RVGE starting as early as 14 days after the first dose

Unexpectedly high burden of rotavirus gastroenteritis in very young infants

<p>Abstract</p> <p>Background</p> <p>The highest incidence of rotavirus gastroenteritis has generally been reported in children 6-24 months of age. Young infants are thought to be partially protected by maternal antibodies acquired transplacentally or via breast milk. The purpose of our study was to assess the age distribution of children with confirmed community-acquired rotavirus gastroenteritis presenting to an urban referral hospital.</p> <p>Methods</p> <p>Children presenting to The Children's Hospital of Philadelphia with acute gastroenteritis have been monitored for the presence of rotavirus antigen in the stool by ELISA (followed by genotyping if ELISA-positive) since the 1994-95 epidemic season.</p> <p>Results</p> <p>Over the last 12 rotavirus seasons prior to the introduction of the pentavalent rotavirus vaccine in 2006, stool specimens from 1646 patients tested positive for community-acquired rotavirus infection. Gender or age was not recorded in 6 and 5 cases, respectively. Overall, 58% of the cases occurred in boys. G1 was the predominant VP7 serotype, accounting for 72% of cases. The median (IQR) age was 11 (5-21) months. A total of 790 (48%) cases occurred in children outside the commonly quoted peak age range, with 27% in infants <6 months of age and 21% in children >24 months of age. A total of 220 (13%) cases occurred during the first 3 months of life, and the highest number of episodes per month of age [97 (6%)] was observed during the second month of life.</p> <p>Conclusions</p> <p>The incidence of community-acquired rotavirus gastroenteritis monitored over 12 seasons in the prevaccine era at a major university hospital was nearly constant for each month of age during the first year of life, revealing an unexpectedly high incidence of symptomatic rotavirus disease in infants <3 months old. A sizeable fraction of cases occurred in children too young to have been vaccinated according to current recommendations.</p

GeoNode-BR: comunidade brasileira para a colaboração entre usuários do software GeoNode.

O GeoNode é uma solução web para o gerenciamento de recursos espaciais [1], e para a implantação de Infraestruturas de Dados Espaciais (IDEs). É uma solução livre e de código aberto, que oferece suporte aos padrões do Open Geoespatial Consortium (OGC) [2], além de ser extensível e interoperável com outras plataformas. O GeoNode possui uma estrutura de metadados baseada na ISO 19115 [3], essa aplicação Free Open Source Software (FOSS) GIS web tem sido uma ótima alternativa para implantar IDE e, por essa razão, tem sido muito adotada por empresas e instituições que possuem grande acervo de dados espaciais no Brasil e no mundo. Desta forma, visando trocar experiências sobre a aplicação FOSS GeoNode, profissionais de gestão de geoinformação da Embrapa, CPRM, ANA, IBGE e Geobases criaram um Grupo de Trabalho (GT) com reuniões periódicas a partir de 2020. Destas reuniões surgiu o interesse em criar uma comunidade brasileira de usuários GeoNode, e organizar um primeiro evento para disseminar, compartilhar e difundir conhecimentos sobre essa aplicação FOSS GIS, além de identificar outras iniciativas, em curso no país, que também estejam utilizando o GeoNode

GeoNode-BR: comunidade brasileira para a colaboração entre usuários do software GeoNode.

O GeoNode é uma solução web para o gerenciamento de recursos espaciais [1], e para a implantação de Infraestruturas de Dados Espaciais (IDEs). É uma solução livre e de código aberto, que oferece suporte aos padrões do Open Geoespatial Consortium (OGC) [2], além de ser extensível e interoperável com outras plataformas. O GeoNode possui uma estrutura de metadados baseada na ISO 19115 [3], essa aplicação Free Open Source Software (FOSS) GIS web tem sido uma ótima alternativa para implantar IDE e, por essa razão, tem sido muito adotada por empresas e instituições que possuem grande acervo de dados espaciais no Brasil e no mundo. Desta forma, visando trocar experiências sobre a aplicação FOSS GeoNode, profissionais de gestão de geoinformação da Embrapa, CPRM, ANA, IBGE e Geobases criaram um Grupo de Trabalho (GT) com reuniões periódicas a partir de 2020. Destas reuniões surgiu o interesse em criar uma comunidade brasileira de usuários GeoNode, e organizar um primeiro evento para disseminar, compartilhar e difundir conhecimentos sobre essa aplicação FOSS GIS, além de identificar outras iniciativas, em curso no país, que também estejam utilizando o GeoNode